证券代码：688617 证券简称：惠泰医疗 公告编号：2026-003 深圳惠泰医疗器械股份有限公司 第三届董事会第三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 深圳惠泰医疗器械股份有限公司（以下简称"公司"）第三届董事会第三次会议通知于2026年2月9日发出 并送达全体董事，全体董事同意豁免本次会议的提前通知时限要求。本次会议于2026年2月9日以现场结 合通讯方式召开，会议应到董事9人，实到董事9人，出席董事占应出席人数的100%。本次会议的召 集、召开及表决程序符合《中华人民共和国公司法》等有关法律、行政法规、规范性文件和《深圳惠泰 医疗器械股份有限公司章程》的规定，会议决议合法有效。经与会董事审议和表决，会议形成决议如 下： 一、审议通过《关于以集中竞价交易方式回购股份方案的议案》 董事会认为，本次回购公司股份方案设计合理，有利于维护广大投资者利益，增强投资者对公司的投资 信心，建立健全公司长效激励机制，促进公司健康可持续发展，全体董事一致同意该事项。 具体内容详见公司同日在上海证券交易所网站（ ...

Core Viewpoint - Shenzhen Huitai Medical Equipment Co., Ltd. has approved a share repurchase plan to enhance investor confidence and establish a long-term incentive mechanism [1] Group 1: Share Repurchase Plan - The company plans to use its own funds to repurchase part of its A-shares through centralized bidding, with a total repurchase amount not less than RMB 150 million and not exceeding RMB 200 million [1] - The maximum repurchase price is set at RMB 315 per share, and the repurchase period is within 10 months from the board's approval date [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives, and if not fully transferred within three years, they will be legally canceled [1] Group 2: Financial Position - As of September 30, 2025, the company's total assets are approximately RMB 3.461 billion, and the net assets attributable to shareholders are about RMB 2.989 billion [1] - Based on the upper limit of the repurchase funds, the repurchase amount accounts for approximately 6.69% of the net assets [1] Group 3: Impact and Confidence - The company believes that the repurchase will not significantly impact its daily operations, finances, or future development, nor will it lead to a change in control or affect its listing status [1] - The decision is based on confidence in the industry outlook and the company's future development [1]

Core Viewpoint - Several companies are engaging in significant transactions, including acquisitions, share repurchases, and performance disclosures, indicating active market movements and strategic adjustments in response to industry conditions [1][2][4][5][6][7][8][9]. Group 1: Acquisitions and Mergers - Efort plans to acquire 100% of Shengpu shares through a combination of share issuance and cash payments, with the transaction expected to enhance business scale and profitability [2]. - Hainan Mining intends to purchase 69.90% of Fengrui Fluorine Industry through share issuance and cash payments, aiming to expand its strategic resource portfolio [9]. - China National Aviation has received approval for a private placement of A-shares, facilitating its capital raising efforts [10]. Group 2: Share Repurchases - Huatai Medical plans to repurchase shares at a price not exceeding 315 CNY per share, with a total repurchase amount between 150 million and 200 million CNY [4]. - Electric Connection Technology aims to repurchase shares for employee stock ownership plans, with a budget of 100 million to 200 million CNY [4]. - Gaweida intends to repurchase shares with a total budget of 30 million to 35 million CNY, aimed at reducing registered capital [4]. Group 3: Performance Reports - Dongwei Technology reported a 2025 net profit increase of 86.81% year-on-year, driven by growth in PCB equipment orders [6]. - Weimais reported a 39.22% increase in net profit for 2025, attributed to the growth in the domestic electric vehicle market [6]. - Qianjin Pharmaceutical's net profit grew by 24.74% in 2025, supported by stable revenue from core industrial enterprises [7]. Group 4: Regulatory and Compliance Issues - Cuihua Jewelry is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [5]. - ST Energy is facing a potential change in control due to share pledges, leading to a trading suspension [12]. Group 5: Investment Projects - Yuanjie Technology plans to invest approximately 12.51 billion CNY in a semiconductor chip and device R&D production base [19]. - Mengguoli intends to invest 9.29 billion CNY in a lithium-ion battery cathode material project, with the first phase already approved [12]. - Optoelectronics plans to issue convertible bonds to raise up to 13.8 billion CNY for expansion projects [17].

Group 1: Major Announcements - Efort plans to acquire 100% of Shengpu shares and will resume trading on February 10 [1][3][4] - Huatai Medical and other companies plan significant share buybacks [1][5] - Zhenghua Jewelry is under investigation by the CSRC for suspected information disclosure violations [1][6] Group 2: Performance Highlights - Dongwei Technology reports a 2025 net profit increase of 86.81% [1][7] - Weimais shows a 39.22% increase in net profit for 2025 [1][8] - Qianjin Pharmaceutical reports a 24.74% increase in net profit for 2025 [1][9] - City Investment Holdings reports a 19.67% increase in net profit for 2025 [1][10] Group 3: Capital Increases and Restructuring - Hainan Mining plans to acquire 69.90% of Fengrui Fluorine Industry through share issuance and cash payment [1][9] - China National Airlines has received approval for a specific stock issuance [1][10] - Andavil has received approval from the CSRC for a specific stock issuance [1][11] - Yuanjie Technology plans to invest 1.251 billion yuan in a semiconductor chip and device R&D production base [1][20] Group 4: Important Events - Sanbo Brain Science's chairman has been released from investigation [1][12] - Yingfeng Co. adjusts its share buyback price cap to no more than 14.00 yuan per share [1][13] - Yitong Century wins a 1.07 billion yuan project with China Tower [1][15] - China Energy plans to acquire 51% of Fujian Investment Group's pumped storage assets for 864 million yuan [1][18]

据统计，2月9日，盘后长虹华意、博威合金、科源制药、高伟达、惠泰医疗、恺英网络、电连技术披露 增持情况。包括长川科技（维权）、欣灵电气、泰达股份、协鑫集成、芯原股份、科士达、海锅股份、 中洲特材、立昂技术、崧盛股份、联盛化学、森霸传感、ST中珠、优德精密（维权）、腾亚精工、远 东股份、万泰生物、宣泰医药、完美世界在内的19家A股上市公司披露减持情况。 | | | 2.9上市公司盘后增持情况 | | --- | --- | --- | | 1 | 长虹华意 | 原高级管理人员何成志增持公司股份 | | 2 | 博威合金 | 控股股东博威集团拟增持公司股份 | | 3 | 科源制药 | 控股股东拟增持不低于5000万元且不超过1亿元公司股份 | | 4 | 高伟达 | 拟以3000万元-3500万元回购公司股份 | | ਦੇ | 惠泰医疗 | 拟以1.5亿至2亿元回购股份用于员工持股计划或股权激励 | | e | 恺英网络 | 拟1亿元-2亿元回购股份 | | 7 | 电连技术 | 拟1亿元-2亿元回购股份 | | | | 2.9上市公司盤后减持情况 | | 1 | 长川科技 | 股东长川投资拟减持不超1.11% ...

Group 1: Financing Optimization - The Shanghai and Shenzhen Stock Exchanges announced a package of measures to optimize refinancing, highlighting a policy direction that favors high-quality and technology-driven companies [1] - The optimization is expected to shorten the refinancing cycle for quality listed companies, allowing them to seize market opportunities and enhance their competitiveness [1] - Enhanced supervision throughout the refinancing process aims to create a healthy market ecosystem, encouraging companies to focus on core businesses and improve profitability [1] Group 2: Automotive Industry Developments - The Ministry of Commerce held a meeting to discuss automotive consumption, planning to implement policies to support the automotive industry, including a vehicle trade-in program by 2026 [2] - Analysts from CITIC Securities noted that while the automotive sector is currently in a weak seasonal performance, there are signs of improving market sentiment and potential for growth in commercial vehicles [2] - A list of undervalued automotive stocks with significant profit growth forecasts was compiled, identifying three stocks with projected net profit increases of over 100% [3] Group 3: Semiconductor Sector - The National Integrated Circuit Industry Investment Fund has been reducing its stakes in several semiconductor companies, which is viewed as a normal investment exit rather than a shift in strategy [7] - The fund's actions have raised market attention, but industry insiders believe the long-term goal of supporting domestic semiconductor growth remains unchanged [7] Group 4: Technology Sector Investments - Major tech companies, including Microsoft and Amazon, are projected to invest over $600 billion in capital expenditures by 2026, primarily in AI infrastructure [4] - NVIDIA's CEO expressed confidence in the sustainability of this investment trend, citing strong future demand for AI infrastructure [4] Group 5: Tax Policies for E-commerce - The Ministry of Finance announced tax exemptions for goods returned due to unsold inventory in cross-border e-commerce, effective from January 1, 2026, to December 31, 2027 [6] Group 6: Labor Rights and Regulations - Several government departments are conducting administrative guidance for major platform and delivery companies to ensure the protection of labor rights for new employment forms [8][9] - Companies are required to improve labor management practices to safeguard the rights of workers in the gig economy [9]

Group 1 - Jinwei Co., Ltd. plans to acquire 100% equity of Fusheng Mining for 210 million yuan, which will become a wholly-owned subsidiary and included in the consolidated financial statements [2] - Mengguli intends to invest 929 million yuan to build a project with an annual production capacity of 30,000 tons of lithium-ion battery cathode materials, expected to produce 5,000 tons of high-voltage cobalt acid lithium, 10,000 tons of NCA materials, and 15,000 tons of ultra-high nickel ternary materials [2] - Xiamen Tungsten plans to acquire 39% equity of Jiujiang Dadi Mining, which will help increase mineral resource reserves and improve raw material self-sufficiency [3] Group 2 - Andavil's subsidiary received EASA certification for its aviation kitchen plug-in products, marking compliance with European aviation safety standards [2] - CIMC Vehicles disclosed that the US ITC made a preliminary ruling on anti-subsidy and anti-dumping investigations regarding Van-Type Trailers, indicating potential damage to the US domestic industry [4] - Source Technology plans to invest approximately 1.251 billion yuan to build a second phase project for the R&D and production of optoelectronic communication semiconductor chips and devices [9] Group 3 - Zhongmin Energy intends to acquire 51% equity of Mintou Pumped Storage for 864 million yuan, with the transaction price based on asset evaluation [10] - Ningbo Yunsheng plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [11] - Wenkai Co., Ltd. won a bid for a landscape project worth 50.8162 million yuan [12] Group 4 - China Merchants Shekou achieved a signed sales amount of 7.674 billion yuan in January 2026 [16] - AVIC Optoelectronics reported a net profit of 2.124 billion yuan for 2025, a year-on-year decrease of 36.69% [17] - Tiankang Bio reported a sales revenue of 392 million yuan from pig sales in January 2026, with a month-on-month increase of 6.23% [18] Group 5 - Poly Developments reported a signed amount of 15.617 billion yuan in January 2026, a year-on-year decrease of 13.31% [19] - Chengtou Holdings reported a net profit of 290 million yuan for 2025, a year-on-year increase of 19.67% [20] - Qianjin Pharmaceutical reported a net profit of 288 million yuan for 2025, a year-on-year increase of 24.74% [21]

Group 1 - Huatai Medical plans to repurchase shares worth between 150 million to 200 million yuan for employee stock ownership plans or equity incentives, with a repurchase price not exceeding 315 yuan per share [1][3] - Aopt plans to raise no more than 1.38 billion yuan for projects related to AI intelligent vision solutions and industrial 3D vision sensors [1][4] - Weimais reported a net profit of 557 million yuan for 2025, a year-on-year increase of 39.22%, despite a slight decline in total revenue [1][6] Group 2 - Jiaokong Technology signed a contract for the Sydney Metro West Line TSMO signal system subcontract project, with a contract value of approximately 93.53 million Australian dollars [1][5] - Microelectrophysiology received EU MDR certification for its magnetic navigation ablation catheter and star-shaped high-density mapping catheter, facilitating entry into the European market [1][4] - Firmus Technologies, an Australian AI infrastructure company, secured 10 billion USD in debt financing led by Blackstone for data center expansion [8][9]

惠泰医疗(688617.SH)发布公告，公司拟1.5亿元至2亿元回购股份，回购股份价格不超过315元/股，回购 的股份将在未来适宜时机用于员工持股计划或股权激励。 ...

智通财经APP讯，惠泰医疗(688617.SH)发布公告，公司拟1.5亿元至2亿元回购股份，回购股份价格不超 过315元/股，回购的股份将在未来适宜时机用于员工持股计划或股权激励。 ...